Auricular Neurostimulation for Cyclic Vomiting Syndrome
NCT03434652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47
Last updated 2026-02-13
Summary
This study evaluates the efficacy of auricular neurostimulation via an non-invasive percutaneous electrical nerve field stimulator in children and adults with cyclic vomiting syndrome.
Conditions
- Cyclic Vomiting Syndrome
- Abdominal Migraine
Interventions
- DEVICE
-
Percutaneous neurostimulation
Auricular percutaneous neurostimulation
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Katja Kovacic, MD · Medical College of Wisconsin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 8 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-31
- Primary Completion
- 2021-03-03
- Completion
- 2021-03-03
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting
NCT00360841 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
NCT03470181 ·Status: COMPLETED
-
Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT02767791 ·Status: COMPLETED ·Phase: NA
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Topical Capsaicin for Cyclical Vomiting
NCT03223350 ·Status: COMPLETED ·Phase: PHASE2
-
Thumbtack Needle in the Treatment of NVP
NCT06566274 ·Status: RECRUITING ·Phase: NA
-
Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS
NCT04329637 ·Status: COMPLETED ·Phase: NA
-
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
NCT06360900 ·Status: RECRUITING ·Phase: NA
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome
NCT04645953 ·Status: COMPLETED ·Phase: PHASE2
-
Noninvasive Markers of Functional Nausea in Children
NCT03593811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
NCT06464926 ·Status: RECRUITING ·Phase: NA
-
Placebo in Acupuncture
NCT01054495 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis
NCT02699385 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
NCT05546359 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints
NCT03061396 ·Status: UNKNOWN ·Phase: NA
-
An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting
NCT06359535 ·Status: RECRUITING ·Phase: PHASE4
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide
NCT01069536 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT05548270 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
NCT01149369 ·Status: COMPLETED ·Phase: PHASE2
-
Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?
NCT03262038 ·Status: TERMINATED ·Phase: PHASE4